TNF-α inhibitor protects against myocardial ischemia/reperfusion injury via Notch1-mediated suppression of oxidative/nitrative stress

Free Radic Biol Med. 2015 May:82:114-21. doi: 10.1016/j.freeradbiomed.2015.02.002. Epub 2015 Feb 11.

Abstract

TNF-α inhibitor reportedly protects against myocardial ischemia/reperfusion (MI/R) injury. It can also increase Notch1 expression in inflammatory bowel disease, revealing the regulation of Notch1 signaling by TNF-α inhibitor. However, the interaction between TNF-α inhibitor and Notch1 signaling in MI/R remains unclear. This study aimed to determine the involvement of TNF-α inhibitor with Notch1 in MI/R and delineate the related mechanism. Notch1-specific small interfering RNA (20 μg) or Jagged1 (a Notch ligand, 12 μg) was delivered through intramyocardial injection. Forty-eight hours after injection, mice received 30 min of myocardial ischemia followed by 3 h (for cell apoptosis and oxidative/nitrative stress) or 24h (for infarct size and cardiac function) of reperfusion. Ten minutes before reperfusion, mice randomly received an intraperitoneal injection of vehicle, etanercept, diphenyleneiodonium, 1400W, or EUK134. Finally, downregulation of Notch1 significantly reversed the alleviation of MI/R injury induced by etanercept, as evidenced by enlarged myocardial infarct size, suppressed cardiac function, and increased myocardial apoptosis. Moreover, Notch1 blockade increased the expression of inducible NO synthase (iNOS) and gp(91)(phox), enhanced NO and superoxide production, and accelerated their cytotoxic reaction product, peroxynitrite. Furthermore, NADPH inhibition with diphenyleneiodonium or iNOS suppression with 1400W mitigated the aggravation of MI/R injury induced by Notch1 downregulation in mice treated with etanercept. Additionally, either Notch1 activation with Jagged1 or peroxynitrite decomposition with EUK134 reduced nitrotyrosine content and attenuated MI/R injury. These data indicate that MI/R injury can be attenuated by TNF-α inhibitor, partly via Notch1 signaling-mediated suppression of oxidative/nitrative stress.

Keywords: Free radicals; Myocardial ischemia/reperfusion; Notch1; Oxidative/nitrative stress; TNF-α inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium-Binding Proteins / genetics
  • Disease Models, Animal
  • Down-Regulation
  • Enzyme Activation
  • Etanercept
  • Intercellular Signaling Peptides and Proteins / genetics
  • Jagged-1 Protein
  • Membrane Proteins / genetics
  • Mice
  • Mice, Inbred C57BL
  • Myocardial Infarction / chemically induced
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / pathology
  • Myocardial Reperfusion Injury / chemically induced
  • Myocardial Reperfusion Injury / drug therapy*
  • Myocardial Reperfusion Injury / pathology
  • Myocardium / pathology
  • NADP / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / biosynthesis
  • Onium Compounds / pharmacology
  • Organometallic Compounds / pharmacology
  • Oxidative Stress / physiology*
  • Peroxynitrous Acid / biosynthesis
  • RNA Interference
  • RNA, Small Interfering
  • Reactive Nitrogen Species / metabolism
  • Reactive Oxygen Species / metabolism
  • Receptor, Notch1 / biosynthesis
  • Receptor, Notch1 / genetics*
  • Receptor, Notch1 / metabolism
  • Salicylates / pharmacology
  • Serrate-Jagged Proteins
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Calcium-Binding Proteins
  • EUK-134
  • Intercellular Signaling Peptides and Proteins
  • Jag1 protein, mouse
  • Jagged-1 Protein
  • Membrane Proteins
  • Notch1 protein, mouse
  • Onium Compounds
  • Organometallic Compounds
  • RNA, Small Interfering
  • Reactive Nitrogen Species
  • Reactive Oxygen Species
  • Receptor, Notch1
  • Salicylates
  • Serrate-Jagged Proteins
  • Tumor Necrosis Factor-alpha
  • Peroxynitrous Acid
  • NADP
  • diphenyleneiodonium
  • Nitric Oxide Synthase Type II
  • Etanercept